Cargando…

Adjuvant radiotherapy in central hepatocellular carcinoma after narrow-margin hepatectomy: A 10-year real-world evidence

OBJECTIVE: A prospective randomized control study investigated the feasibility and efficacy of adjuvant radiotherapy on patients with central hepatocellular carcinoma (HCC) after narrow-margin hepatectomy (<1 cm). This study presents an updated 10-year real-world evidence to further characterize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rong, Weiqi, Yu, Weibo, Wang, Liming, Wu, Fan, Zhang, Kai, Chen, Bo, Miao, Chengli, Liu, Liguo, An, Songlin, Tao, Changcheng, Wang, Weihu, Wu, Jianxiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666779/ https://www.ncbi.nlm.nih.gov/pubmed/33223759 http://dx.doi.org/10.21147/j.issn.1000-9604.2020.05.09

Ejemplares similares

The role of intraoperative electron radiotherapy in centrally located hepatocellular carcinomas treated with narrow-margin (<1 cm) hepatectomy: a prospective, phase 2 study
por: Wang, Liming, et al.
Publicado: (2022)

Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC
por: Chen, Bo, et al.
Publicado: (2021)

Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion
por: Wang, Liming, et al.
Publicado: (2017)

Benefit of adjuvant radiotherapy following narrow-margin hepatectomy in patients with intrahepatic cholangiocarcinoma that adhere to major vessels
por: Zheng, Xuan, et al.
Publicado: (2018)

Recurrence Patterns After Hepatectomy With Very Narrow Resection Margins for Hepatocellular Carcinoma
por: Cheng, Chih-Hsien, et al.
Publicado: (2022)

Identification of recurrence-related serum microRNAs in hepatocellular carcinoma following hepatectomy
por: Wang, Liming, et al.
Publicado: (2015)

Elevated Pretherapy Serum IL17 in Primary Hepatocellular Carcinoma Patients Correlate to Increased Risk of Early Recurrence after Curative Hepatectomy
por: Wu, Jianxiong, et al.
Publicado: (2012)

Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study
por: Wang, Liming, et al.
Publicado: (2020)

Clinical Benefits of Neoadjuvant Radiotherapy on the Postoperative Recurrence of Centrally Located Hepatocellular Carcinoma: A Real-World Evidence Based on Phase II Clinical Trial
por: Tao, Changcheng, et al.
Publicado: (2023)

Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis
por: Wang, Liming, et al.
Publicado: (2019)

Narrow-Margin Hepatectomy Resulted in Higher Recurrence and Lower Overall Survival for R0 Resection Hepatocellular Carcinoma
por: Liu, Lihong, et al.
Publicado: (2021)

Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE
por: Bai, Shilei, et al.
Publicado: (2023)

Enhanced recovery after surgery strategy for cirrhosis patients undergoing hepatectomy: experience in a single research center
por: Zheng, Yiling, et al.
Publicado: (2020)

Regional Ischemic Preconditioning Has Clinical Value in Cirrhotic HCC Through MAPK Pathways
por: Wang, Liming, et al.
Publicado: (2018)

Lymphoepithelioma-like carcinoma in liver not associated with Epstein-Barr virus: a report of 3 cases and literature review
por: Zhang, Kai, et al.
Publicado: (2020)

Establishment, validation and evaluation of predictive model for early relapse after R0 resection in hepatocellular carcinoma patients with microvascular invasion
por: Zhang, Kai, et al.
Publicado: (2021)

Establishment and Evaluation of a Predictive Model for Early Postoperative Recurrence of Hepatocellular Carcinoma in Patients with Microvascular Invasion
por: Zhang, Kai, et al.
Publicado: (2021)

A Novel Nomogram for Predicting Postoperative Liver Failure After Major Hepatectomy for Hepatocellular Carcinoma
por: Lei, Zhengqing, et al.
Publicado: (2022)

A novel scoring system predicts adjuvant chemolipiodolization benefit for hepatocellular carcinoma patients after hepatectomy
por: Huang, Li-feng, et al.
Publicado: (2016)

One- versus two-stage partial hepatectomy for large resectable solitary hepatocellular carcinomas determined preoperatively to have a narrow resection margin: a propensity score matching analysis
por: Li, Yao, et al.
Publicado: (2022)

Effect of surgical margin in R0 hepatectomy on recurrence-free survival of patients with solitary hepatocellular carcinomas without macroscopic vascular invasion
por: Dong, Sheng, et al.
Publicado: (2016)

Integrated analysis of the rhesus monkey liver transcriptome during development and human primary HCC AFP-related gene expression
por: Feng, Lin, et al.
Publicado: (2021)

A narrative review of near-infrared fluorescence imaging in hepatectomy for hepatocellular carcinoma
por: Zhang, Weiqi, et al.
Publicado: (2021)

Prognostic Impact of Surgical Margin in Hepatectomy on Patients With Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies
por: Lin, Yeting, et al.
Publicado: (2022)

Adjuvant Iodine-125 Brachytherapy for Hepatocellular Carcinoma after Complete Hepatectomy: A Randomized Controlled Trial
por: Chen, Kaiyun, et al.
Publicado: (2013)

Is laparoscopic hepatectomy superior to open hepatectomy for hepatocellular carcinoma?
por: Zhong, Jian-Hong, et al.
Publicado: (2017)

A Preoperative Measurement of Serum MicroRNA-125b May Predict the Presence of Microvascular Invasion in Hepatocellular Carcinomas Patients
por: Liu, Mei, et al.
Publicado: (2016)

Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial
por: Rong, Weiqi, et al.
Publicado: (2022)

Adjuvant Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy
por: Zhang, Yue-Lin, et al.
Publicado: (2020)

Hepatectomy plus adjuvant transcatheter arterial chemoembolization improves the survival rate of patients with multicentric occurrence of hepatocellular carcinoma
por: Xu, Da, et al.
Publicado: (2018)

Narrow safety margin in the phyllosphere during thermal extremes
por: Pincebourde, Sylvain, et al.
Publicado: (2019)

Narrow-Margin Excision for Invasive Acral Melanoma: Is It Acceptable?
por: Ito, Takamichi, et al.
Publicado: (2020)

Survival Benefits From Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma and Microvascular Invasion After Curative Hepatectomy
por: Dai, Mu-Gen, et al.
Publicado: (2023)

ABO blood type correlates with survival in hepatocellular carcinoma following hepatectomy
por: Wu, Tao, et al.
Publicado: (2017)

Adjuvant Transarterial Chemoembolization Following Curative-Intent Hepatectomy Versus Hepatectomy Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Esagian, Stepan M., et al.
Publicado: (2021)

Clinical and Pathological Study of Tumor Border Invasion—Is Narrow Resection Margin Acceptable in Hepatoblastoma Surgery?
por: Shen, Gang, et al.
Publicado: (2020)

Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma
por: Wang, Hongzhi, et al.
Publicado: (2022)

Primary Cutaneous Mucinous Carcinoma Treated with Narrow Surgical Margin
por: Choi, Jin-Hee, et al.
Publicado: (2016)

Prognostic Impact of Surgical Margin Width in Hepatectomy for Colorectal Liver Metastasis
por: Sakamoto, Katsunori, et al.
Publicado: (2023)

Simultaneous hepatectomy and splenectomy versus hepatectomy alone for hepatocellular carcinoma complicated by hypersplenism: a meta-analysis
por: Li, Wei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v7m3b2jn9plbaia7ru0t1jgr29